Search Results - "Gildas Baulier"
-
1
Guidelines for prophylaxis of Pneumocystis pneumonia cannot rely solely on CD4-cell count in autoimmune and inflammatory diseases
Published in Clinical and experimental rheumatology (01-05-2018)“…Guidelines for preventing Pneumocystis pneumonia (PCP) in HIV patients are based on CD4 below 200/mm3. Such cut-off value is suggested to guide prophylaxis in…”
Get full text
Journal Article -
2
-
3
Romidepsin is an effective and well-tolerated therapy in CD3−CD4+ lymphocyte-variant hypereosinophilic syndrome: A case report
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01-11-2019)“…L-HES is characterized by the presence of an abnormal T-cell clone, typically with a CD3−CD4+ immunophenotype, capable of secreting eosinophilopoïetic…”
Get full text
Journal Article -
4
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)Research in context
Published in EClinicalMedicine (01-07-2024)“…Background: Erdheim-Chester disease (ECD) is a rare histiocytosis that may overlap with Langerhans Cell Histiocytosis (LCH). This “mixed” entity is poorly…”
Get full text
Journal Article -
5
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)
Published in EClinicalMedicine (01-07-2024)“…Erdheim-Chester disease (ECD) is a rare histiocytosis that may overlap with Langerhans Cell Histiocytosis (LCH). This “mixed” entity is poorly characterized…”
Get full text
Journal Article -
6
Contribution of the qPCR for the Diagnosis of Pneumocystosis
Published in Open forum infectious diseases (04-10-2017)“…Abstract Background Pneumocystis jirovecii pneumonia (PCP) is an opportunistic fungal respiratory infection. The incidence of PCP has decreased among HIV…”
Get full text
Journal Article -
7
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)
Published in Rheumatic & musculoskeletal diseases open (01-11-2022)“…ObjectivesTo assess the tolerance and efficacy of targeted therapies prescribed off-label in refractory low-prevalence autoimmune and inflammatory systemic…”
Get full text
Journal Article -
8
Diagnosis of Pneumocystis jirovecii Pneumonia in an Intensive Care Unit: A 3-Year Prospective Study
Published in Open forum infectious diseases (01-12-2016)Get full text
Journal Article -
9
Cocaïne et lésions destructrices centro-faciales : à propos d'un cas
Published in La revue de medecine interne (01-09-2020)“…La consommation de cocaïne est associée à de multiples complications dont certaines peuvent mimer des maladies systémiques, particulièrement des vascularites…”
Get full text
Journal Article -
10
-
11